“The head of the US Food and Drug Administration has said he is willing to bypass the normal approval process to authorise a Covid-19 vaccine as soon as possible — but has insisted he will not do so to please President Trump,” the Financial Times reports.
“Stephen Hahn said his agency was prepared to authorise a vaccine before Phase Three clinical trials were complete, as long as officials believed the benefits outweighed the risks. But he defended his embattled organisation against accusations that it was rushing the process to boost Mr Trump’s re-election prospects.”
Save to Favorites